The M5 muscarinic acetylcholine receptor represents a promising therapeutic target for neurological disorders. Here, the authors reveal a 2.1 Å cryo-EM structure of the M5 bound to a selective positive allosteric modulator site that enables structure-based drug design.
- Wessel A. C. Burger
- Jesse I. Mobbs
- David M. Thal